Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
Latest Information Update: 16 Mar 2023
At a glance
- Drugs K 161 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Kowa Research Institute
Most Recent Events
- 13 Mar 2020 Status changed from recruiting to completed.
- 09 Sep 2019 Status changed from planning to recruiting.
- 22 Feb 2019 New trial record